Treatment of Renin-Angiotensin-Aldosterone System Dysfunction With Angiotensin II in High-Renin Septic Shock

Semin Cardiothorac Vasc Anesth. 2021 Mar;25(1):67-73. doi: 10.1177/1089253220949070. Epub 2020 Aug 12.

Abstract

Endothelial dysfunction is common in septic shock and has been shown to impair angiotensin converting enzyme and the renin-angiotensin-aldosterone system (RAAS). Dysregulation of this pathway, which can be measured with plasma renin activity (PRA), is important not only because RAAS dysfunction is associated with increased mortality but also because treatment with angiotensin II (Ang-2) has been shown to decrease mortality. In this case series of 2 patients, serial PRA levels identified septic shock patients with RAAS dysfunction. The patients were treated with Ang-2, an angiotensin type 1 receptor agonist, which resulted in significant improvements in hemodynamics and PRA levels during treatment.

Keywords: angiotensin II; renin; renin-angiotensin-aldosterone system; sepsis; septic shock.

Publication types

  • Case Reports

MeSH terms

  • Angiotensin II / therapeutic use*
  • Female
  • Humans
  • Male
  • Middle Aged
  • Renin / blood*
  • Renin-Angiotensin System / drug effects*
  • Shock, Septic / blood*
  • Shock, Septic / drug therapy*
  • Treatment Outcome
  • Vasoconstrictor Agents / therapeutic use*

Substances

  • Vasoconstrictor Agents
  • Angiotensin II
  • Renin